TET2, a DNA methylcytosine dioxygenase, functions as a tumor suppressor in hematopoietic malignancies [8–10]. Many studies report that demethylase activity of TET2 is essential for its tumor inhibitory effect [10–13]. Here, MBD2 is linked to neoplasm.